Startup Treeline Bio Emerges From the Shadows With $1B+ Raised and 3 Cancer Drugs in the Clinic

Eschewing the traditional model of financing biotech startups milestone to milestone to support a lead asset, Treeline Biosciences’ well-funded pipeline is comprised of multiple complementary programs. Select investors have supported the approach of Treeline, which said it has raised more than $1.1 billion to date. The post Startup Treeline Bio Emerges From the Shadows With…

Read More

Caregiver risk preferences for delaying loss of ambulation in Duchenne muscular dystrophy

That is the title of a paper published today in Current Medical Research and Opinion with co-authors Nadine Zawadzki, Moises Marin, Ivana Audhya, Lauren Sedita, Natasha Kulkarni and Alexa Klimchak. The abstract is below. ObjectivesQuantify caregiver risk preferences to inform the “value of hope” for Duchenne muscular dystrophy (DMD) therapies affecting time to loss of…

Read More

Watch: How Controversies Over Vaccine Changes Affect You

Céline Gounder, KFF Health News’ editor-at-large for public health, appeared on CBS News’ “Face the Nation With Margaret Brennan” on Aug. 31 to discuss leadership changes at the Centers for Disease Control and Prevention and vaccine policy concerns. Gounder noted that the departures of top officials and confusion over how to get vaccines affect the…

Read More

Easing Frontline Pressure: How AI Can Lift the Administrative Burden Off Care Teams

AI agents excel in operating within compliance frameworks, offloading structured tasks while escalating edge cases to human providers. They show great promise in helping reclaim clinical capacity and reduce the mounting administration associated with modern medicine. The post Easing Frontline Pressure: How AI Can Lift the Administrative Burden Off Care Teams appeared first on MedCity…

Read More